Sanjeev is the Head of Business Operations at Global Blood Therapeutics (GBT) where he is responsible for bringing the company’s innovations to patients impacted by Sickle Cell Disease. Prior to GBT, Sanjeev worked at Takeda/ Shire and was responsible for developing and commercializing a novel pipeline asset across three rare hematological conditions including sickle cell disease.
Sanjeev spent ~10 years at Shire in the US and Switzerland locations where he has held numerous leadership positions across Global Strategy and Brand Teams, Corporate Development, and International Commercial organizations. Earlier in his career, Sanjeev was a life sciences consultant with clients across the US and European biotech sectors.